Effective Duty Rate
0% MFN for most finished drugs; some intermediates 3%–6.5%
Estimate — verify by HTS code
Compliance Risk
Medium
Relative to other import corridors
Regulatory Agencies
FDA, DEA, EPA
Primary oversight bodies
OVERVIEW
Importing Pharmaceutical Products & Active Ingredients from India
Pharmaceuticals imported from India to the United States is subject to CBP entry requirements, applicable HTS-based duty rates, and agency compliance clearances. This guide covers the complete import process for 2026.
⚠ Key Trade Intelligence — India Origin
India is the largest global supplier of generic pharmaceuticals and a top-3 API producer. Most finished drugs enter at 0% under WTO Pharma Agreement. FDA conducts extensive facility inspections in India. Import alerts and warning letters have affected some Indian pharma manufacturers.
APPLICABLE HTS CODES
HTS Codes for Pharmaceuticals Imports
The following Harmonized Tariff Schedule (HTS) codes typically apply to pharmaceuticals imports. Exact classification depends on the specific product — misclassification is one of the most common CBP compliance errors.
| HTS Code |
Product Description |
MFN Base Duty Rate |
| 3003 |
Medicaments (not in measured doses) |
0% MFN |
| 3004 |
Medicaments in Measured Doses (retail packaged) |
0% MFN |
| 3002 |
Vaccines, Blood Products & Antisera |
0% MFN |
| 2941 |
Antibiotics (bulk active pharmaceutical ingredients) |
0% MFN (WTO Pharma Agreement) |
| 2942 |
Other Organic Compounds (pharma intermediates) |
0%–6.5% MFN |
MFN rates reflect base tariff. Additional duties (Section 301, Section 232, AD/CVD) may apply on top of MFN rates. Use the AI classifier to get the exact 10-digit HTS code and all applicable rates for your specific product.
DUTY STACK — INDIA ORIGIN
Total Tariff Cost for India-Origin Pharmaceuticals
| Duty Layer |
Rate / Status |
Applies To |
| MFN Base Rate |
Varies by HTS code |
All India-origin goods (baseline) |
| Section 301 |
Not applicable |
India-origin goods are not subject to Section 301 |
| Section 232 (Steel/Aluminum) |
25% steel / 10% aluminum |
Steel and aluminum imports from India |
COMPLIANCE — FDA / DEA / EPA
US Compliance Requirements for Pharmaceuticals Imports
Regardless of origin country, pharmaceuticals imports must satisfy the following US regulatory requirements before or at the time of CBP entry filing:
- FDA prior notice of imported food/drug shipments — FDA Form 2877 (Entry Notice) required; finished drugs must comply with NDA/ANDA or be the subject of an approved IND
- cGMP (Current Good Manufacturing Practice) compliance — FDA may inspect foreign manufacturing facilities; Drug Master File (DMF) required for active ingredients
- DEA registration and import permit required for Schedule II–V controlled substances; Form DEA-236 Import Declaration
- FDA Establishment Registration and Drug Listing — foreign manufacturers must register with FDA and list all drugs they manufacture for US distribution
Compliance Check Tool
Run an automated compliance check for your pharmaceuticals import — identifies all applicable agency requirements, flagging issues before your shipment departs India.
Run Compliance Check →
REQUIRED DOCUMENTS
Documentation Checklist for Pharmaceuticals from India
Prepare all documents before the shipment departs India. Missing or incorrect documents are the #1 cause of CBP holds and customs delays.
1
Commercial Invoice with drug name (INN/USAN), strength, dosage form, and NDA/ANDA number
2
Packing List with batch/lot numbers
3
Bill of Lading or Airway Bill (temperature-controlled documentation for cold-chain products)
4
FDA Drug Import Entry form and Prior Notice confirmation
5
Certificate of Analysis (CoA) for each batch/lot
6
cGMP compliance certificate from manufacturing facility
ESTIMATED TIMELINE
Import Timeline — Pharmaceuticals from India
3–7 days (air freight for temperature-sensitive products); 15–30 days (ocean for bulk APIs)
Supplier Preparation
Allow 1–2 weeks for production documentation, certificates, and packing lists
Transit Time
18–35 days ocean from Asia/origin
CBP Clearance
1–3 days standard; 5–15 days if examination or AD/CVD review required
FREQUENTLY ASKED QUESTIONS
FAQs — Importing Pharmaceuticals from India
What is the effective US tariff rate for importing pharmaceuticals from India?
The effective US tariff rate for pharmaceuticals from India is: 0% MFN for most finished drugs; some intermediates 3%–6.5%. India is the largest global supplier of generic pharmaceuticals and a top-3 API producer. Most finished drugs enter at 0% under WTO Pharma Agreement. FDA conducts extensive facility inspections in India. Import alerts and warning letters have affected some Indian pharma manufacturers.
What compliance agencies regulate pharmaceuticals imports from India?
Pharmaceuticals imports require compliance with: FDA, DEA, EPA. Specific requirements include: FDA prior notice of imported food/drug shipments — FDA Form 2877 (Entry Notice) required; finished drugs must comply with NDA/ANDA or be the subject of an approved IND and cGMP (Current Good Manufacturing Practice) compliance — FDA may inspect foreign manufacturing facilities; Drug Master File (DMF) required for active ingredients.
What documents are required to import pharmaceuticals from India?
Required documents include: Commercial Invoice with drug name (INN/USAN), strength, dosage form, and NDA/ANDA number; Packing List with batch/lot numbers; Bill of Lading or Airway Bill (temperature-controlled documentation for cold-chain products); FDA Drug Import Entry form and Prior Notice confirmation. Additional: Certificate of Analysis (CoA) for each batch/lot; cGMP compliance certificate from manufacturing facility. Ensure all documents are prepared before the shipment departs India.
How long does customs clearance take for pharmaceuticals from India?
Typical timeline: 3–7 days (air freight for temperature-sensitive products); 15–30 days (ocean for bulk APIs). CBP clearance typically takes 1–3 business days for compliant entries. Complex entries (AD/CVD, formal entry review, or examination) may require 5–15 additional business days.
Are there Section 301 or Section 232 tariffs on pharmaceuticals from India?
No Section 301 tariffs apply to India-origin goods. Section 232 applies: 25% on steel and 10% on aluminum products from India.
Ready to Calculate Your Exact Import Costs?
Get precise duty calculations, landed cost estimates, and compliance flags for your pharmaceuticals shipment from India.
RELATED IMPORT GUIDES
Also Importing Pharmaceuticals From Other Countries?
Other Products from India?
Import duty rates are sourced from the USITC Harmonized Tariff Schedule and USTR Section 301 lists. Rates reflect current published schedules as of 2026-04-06 and are subject to change. This page is for informational purposes only and does not constitute legal or customs brokerage advice. Verify rates with a licensed customs broker before importing.